A Study to Evaluate the Drug-Drug Interaction of EDP-323 With Midazolam, Caffeine, and Rosuvastatin in Healthy Participants
Clinical trial NCT06917508 · COMPLETED
Trial details
- NCT number
- NCT06917508
- Sponsor
- Enanta Pharmaceuticals, Inc
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2025-03-13
- Primary completion
- 2025-06-06
- Enrollment
- 24
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.